Indaptus Therapeutics Inc (INDP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $422.38M
Last updated: Nov 17, 2026 at 4:41 PM ET
Indaptus Therapeutics Inc (INDP) Statistics
Indaptus Therapeutics (INDP) has a market cap of $422.38M and an enterprise value of $395.77M. Its share count is up 13263.82% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 6.30% below the market cap, as cash exceeds debt.
| Market Cap | $422.38M |
|---|---|
| Enterprise Value | $395.77M |
| Latest price (Nov 17, 2026) | $3.32 |
Key Dates
The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 15, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 32.27% over 52 weeks and trades 9.57% above its 50-day average.
| Beta (1Y) | 1.59 |
|---|---|
| 52-Week Change | +32.27% |
| 1-Month Change | +21.61% |
| 3-Month Change | +253.19% |
| 6-Month Change | +149.62% |
| 5-Year Change | -98.46% |
| 10-Year Change | -99.97% |
| Total Return (1Y) | +32.27% |
| Total Return (3Y CAGR) | -61.38% |
| Total Return (5Y CAGR) | -53.75% |
| Return vs SPY (1Y) | +32.16% |
| Max Drawdown (1Y) | -80.29% |
| Max Drawdown (3Y) | -98.81% |
| Sharpe Ratio (1Y) | 0.20 |
| Correlation with SPY (1Y) | 0.12 |
| 50-Day Average | $3.03 |
| 200-Day Average | $2.33 |
| 52-Week Range | $0.92 to $5.96 |
| RSI (14 Days) | 54.8 |
| Average Volume (20 Days) | 251.61K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 94.60x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 94.60x |
|---|---|
| Quick Ratio | 94.60x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -130.63% and return on assets is -43.24% over the last 12 months.
| Return on Equity (ROE) | -130.63% |
|---|---|
| Return on Assets (ROA) | -43.24% |
| Return on Capital Employed (ROCE) | -44.30% |
Scores
INDP has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$13.26M |
| Pretax Income | -$13.68M |
| Net Income | -$13.50M |
| EBIT | -$13.68M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 33.10% of the $31.21M in total assets.
| Cash and Equivalents | $26.60M |
|---|---|
| Total Debt | $0 |
| Net Cash | $26.60M |
| Net Cash Per Share | $0.20 |
| Working Capital | $30.88M |
| Shareholder Equity | $10.33M |
| Book Value Per Share | $0.08 |
| Total Assets | $31.21M |
| Total Liabilities | $20.88M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$13.56M |
|---|---|
| FCF Per Share | -$0.10 |
| Share Repurchases | $207.91K |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | +0.42% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +0.42% |
Dividends and Yields
INDP does not pay a dividend.
| Buyback Yield | -2.67% |
|---|---|
| Shareholder Yield | -2.67% |
Stock Splits
The last split was a 1-for-28 reverse split on Jun 27, 2025.
| Last Split Date | Jun 27, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:28 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About INDP
What is INDP's market cap?
Indaptus Therapeutics has a market cap of $422.38M. Its enterprise value, which adds debt and subtracts cash, is $395.77M.
How many shares of INDP are outstanding?
Indaptus Therapeutics has 133.24M shares outstanding. The count is up 13263.82% from a year earlier.
Does INDP pay a dividend?
No. Indaptus Therapeutics does not pay a dividend.
How much debt does INDP have?
Indaptus Therapeutics has $0 of total debt and $26.60M of cash and equivalents, a net cash position of $26.60M.
INDP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors